Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product (Inhalers, Injection Devices, Transdermal Patches), By Application (Oncology, Infectious Diseases, Respiratory Diseases, Diabetes), By End Use, By Region, And Segment Forecasts,
Description
Drug Delivery Devices Market Summary
The global drug delivery devices market size was valued at USD 463.8 billion in 2025 and is projected to reach USD 841.4 billion by 2033, growing at a CAGR of 7.8% from 2026 to 2033. The growing adoption of advanced technology for precise drug delivery is driving market expansion.
In June 2024, Aptar Digital Health and SHL Medical partnered to enhance injectable therapy experiences by integrating Aptar’s SaMD platform with SHL’s connected drug delivery solutions, including the Molly Connected Cap. This collaboration aims to improve self-injection therapy through digital health innovations. These devices optimize the connected drug delivery devices market, minimizing dosage and side effects, which lowers costs by reducing active pharmaceutical ingredient use. The novel drug delivery devices market is also anticipated to witness accelerated R&D efforts owing to rising demand.
Drug delivery devices are used for conditions such as asthma, chronic obstructive pulmonary disease (COPD), diabetes, cancer, cardiovascular diseases, and chronic pain. These devices ensure precise, targeted delivery of medications, improving efficacy and patient compliance while minimizing side effects. According to the Asthma and Allergy Foundation of America, Asthma affects over 27 million people in the U.S., roughly 1 in 12 individuals. Among adults aged 18 and older, over 22 million have asthma, with a higher prevalence in females (10.8%) compared to males (6.5%). Asthma ranks among the most common and expensive diseases in the U.S. For instance, according to National Asthma Council Australia Ltd, the Salflumix Easyhaler, added to the Pharmaceutical Benefits Scheme (PBS) on April 1, 2024, treats asthma and COPD with fluticasone propionate/salmeterol in two strengths: 250/50 and 500/50. It is a dry powder inhaler that requires shaking before use and has a dose counter. The Easyhaler is suitable for various ages and disease severities. In addition, it is entirely carbon neutral.
The rising elderly population has heightened the need for subcutaneous devices for diagnosing and treating various chronic health conditions. Studies indicate that individuals aged 65 and older face increased risks of serious ailments such as heart disease, asthma, respiratory infections, COPD, diabetes, and other disorders, as aging weakens the immune system, thus driving the subcutaneous drug delivery devices market.
Global Drug Delivery Devices Market Report Segmentation
This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global drug delivery devices market report on the basis of product, application, end use, and region:
The global drug delivery devices market size was valued at USD 463.8 billion in 2025 and is projected to reach USD 841.4 billion by 2033, growing at a CAGR of 7.8% from 2026 to 2033. The growing adoption of advanced technology for precise drug delivery is driving market expansion.
In June 2024, Aptar Digital Health and SHL Medical partnered to enhance injectable therapy experiences by integrating Aptar’s SaMD platform with SHL’s connected drug delivery solutions, including the Molly Connected Cap. This collaboration aims to improve self-injection therapy through digital health innovations. These devices optimize the connected drug delivery devices market, minimizing dosage and side effects, which lowers costs by reducing active pharmaceutical ingredient use. The novel drug delivery devices market is also anticipated to witness accelerated R&D efforts owing to rising demand.
Drug delivery devices are used for conditions such as asthma, chronic obstructive pulmonary disease (COPD), diabetes, cancer, cardiovascular diseases, and chronic pain. These devices ensure precise, targeted delivery of medications, improving efficacy and patient compliance while minimizing side effects. According to the Asthma and Allergy Foundation of America, Asthma affects over 27 million people in the U.S., roughly 1 in 12 individuals. Among adults aged 18 and older, over 22 million have asthma, with a higher prevalence in females (10.8%) compared to males (6.5%). Asthma ranks among the most common and expensive diseases in the U.S. For instance, according to National Asthma Council Australia Ltd, the Salflumix Easyhaler, added to the Pharmaceutical Benefits Scheme (PBS) on April 1, 2024, treats asthma and COPD with fluticasone propionate/salmeterol in two strengths: 250/50 and 500/50. It is a dry powder inhaler that requires shaking before use and has a dose counter. The Easyhaler is suitable for various ages and disease severities. In addition, it is entirely carbon neutral.
The rising elderly population has heightened the need for subcutaneous devices for diagnosing and treating various chronic health conditions. Studies indicate that individuals aged 65 and older face increased risks of serious ailments such as heart disease, asthma, respiratory infections, COPD, diabetes, and other disorders, as aging weakens the immune system, thus driving the subcutaneous drug delivery devices market.
Global Drug Delivery Devices Market Report Segmentation
This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global drug delivery devices market report on the basis of product, application, end use, and region:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Inhalers
- Metered-dose inhalers (MDIs)
- Dry powder inhalers (DPIs)
- Others
- Injection Devices
- Prefilled Syringes
- Auto-injectors
- Pen injectors
- Needle-free injectors
- Wearable injectors
- Implants
- Contraceptive implants
- Drug-eluting stents
- Biodegradable implants
- Topical Delivery System
- Creams
- Gels
- Ointments
- Oral Delivery System
- Controlled-release tablets and capsules
- Buccal and sublingual tablets
- Occular Delivery System
- Nebulizers
- Transdermal Patches
- Infusion Pumps
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Oncology
- Infectious Diseases
- Respiratory Diseases
- Diabetes
- Cardiovascular Diseases
- Autoimmune Diseases
- Central Nervous System Disorders
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Diagnostic Centers
- Ambulatory Surgery Centers/Clinics
- Home Care Settings
- Others
- Region Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
200 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR’s Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Number of Surgical Procedures
- 3.2.1.2. Growing Focus On Perioperative Normothermia and Increasing Adoption of Targeted Temperature Management (TTM) In Critical Care
- 3.2.1.3. Technological advancements and the integration of digital health systems
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High Cost of Temperature Management Systems
- 3.2.2.2. Safety concerns and misuse of patient temperature management devices
- 3.2.3. Industry Opportunity Analysis
- 3.2.4. Industry Challenge Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Porter’s Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.2.5. Legal Landscape
- 3.4. Sustainability Commentary
- 3.4.1. Regulatory Drivers Around Sustainability and Eco-Compliance
- 3.4.2. Adoption of Reusable and Energy-Efficient Systems
- 3.4.3. Industry Initiatives Towards Waste Reduction
- 3.4.4. Manufacturer-Level Actions for Greener Operations
- Chapter 4. Patient Temperature Management Market: Product Estimates & Trend Analysis
- 4.1. Product Segment Dashboard
- 4.2. Product Market Share Movement Analysis, 2025 & 2033
- 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
- 4.4. Convective Warming
- 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Temperature Monitoring
- 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Blood/Fluid Warming
- 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.7. Conductive Warming
- 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.8. Passive Warming (Blankets)
- 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.9. Patient Cooling
- 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Patient Temperature Management Market: Application Estimates & Trend Analysis
- 5.1. Application Dashboard
- 5.2. Application Market Share Movement Analysis, 2025 & 2033
- 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 5.4. General Surgery
- 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Cardiology
- 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Pediatrics
- 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Neurology
- 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.8. Orthopedic Surgery
- 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.9. Thoracic Surgery
- 5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.10. Others
- 5.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Patient Temperature Management Market: End Use Estimates & Trend Analysis
- 6.1. End use Segment Dashboard
- 6.2. End use Market Share Movement Analysis, 2025 & 2033
- 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 6.4. Operating rooms
- 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Neonatal Care
- 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. ICUs
- 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7. Emergency room
- 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8. Preoperative Care Units
- 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.9. Postoperative Care Units
- 6.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.10. Acute Care
- 6.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.11. Burn Centers
- 6.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.12. Cath Labs
- 6.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.13. Neurological Care Units
- 6.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.14. Others
- 6.14.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Patient Temperature Management Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Dashboard
- 7.2. Regional Market: Key Takeaways
- 7.3. North America
- 7.3.1. North America Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key country dynamic
- 7.3.2.2. Regulatory framework
- 7.3.2.3. Competitive insights
- 7.3.2.4. U.S. Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key country dynamic
- 7.3.3.2. Regulatory framework
- 7.3.3.3. Competitive insights
- 7.3.3.4. Canada Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key country dynamic
- 7.3.4.2. Regulatory framework
- 7.3.4.3. Competitive insights
- 7.3.4.4. Mexico Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4. Europe
- 7.4.1. Europe Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Key country dynamic
- 7.4.2.2. Regulatory framework
- 7.4.2.3. Competitive insights
- 7.4.2.4. Germany Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.3. UK
- 7.4.3.1. Key country dynamic
- 7.4.3.2. Regulatory framework
- 7.4.3.3. Competitive insights
- 7.4.3.4. UK Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key country dynamic
- 7.4.4.2. Regulatory framework
- 7.4.4.3. Competitive insights
- 7.4.4.4. France Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key country dynamic
- 7.4.5.2. Regulatory framework
- 7.4.5.3. Competitive insights
- 7.4.5.4. Italy Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key country dynamic
- 7.4.6.2. Regulatory framework
- 7.4.6.3. Competitive insights
- 7.4.6.4. Spain Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key country dynamic
- 7.4.7.2. Regulatory framework
- 7.4.7.3. Competitive insights
- 7.4.7.4. Denmark Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key country dynamic
- 7.4.8.2. Regulatory framework
- 7.4.8.3. Competitive insights
- 7.4.8.4. Sweden Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key country dynamic
- 7.4.9.2. Regulatory framework
- 7.4.9.3. Competitive insights
- 7.4.9.4. Norway Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key country dynamic
- 7.5.2.2. Regulatory framework
- 7.5.2.3. Competitive insights
- 7.5.2.4. Japan Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key country dynamic
- 7.5.3.2. Regulatory framework
- 7.5.3.3. Competitive insights
- 7.5.3.4. China Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key country dynamic
- 7.5.4.2. Regulatory framework
- 7.5.4.3. Competitive insights
- 7.5.4.4. India Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key country dynamic
- 7.5.5.2. Regulatory framework
- 7.5.5.3. Competitive insights
- 7.5.5.4. South Korea Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Australia
- 7.5.6.1. Key country dynamic
- 7.5.6.2. Regulatory framework
- 7.5.6.3. Competitive insights
- 7.5.6.4. Australia Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Thailand
- 7.5.7.1. Key country dynamic
- 7.5.7.2. Regulatory framework
- 7.5.7.3. Competitive insights
- 7.5.7.4. Thailand Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America Patient Temperature Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key country dynamic
- 7.6.2.2. Regulatory framework
- 7.6.2.3. Competitive insights
- 7.6.2.4. Brazil Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key country dynamic
- 7.6.3.2. Regulatory framework
- 7.6.3.3. Competitive insights
- 7.6.3.4. Argentina Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7. MEA
- 7.7.1. MEA Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key country dynamic
- 7.7.2.2. Regulatory framework
- 7.7.2.3. Competitive insights
- 7.7.2.4. South Africa Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key country dynamic
- 7.7.3.2. Regulatory framework
- 7.7.3.3. Competitive insights
- 7.7.3.4. Saudi Arabia Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key country dynamic
- 7.7.4.2. Regulatory framework
- 7.7.4.3. Competitive insights
- 7.7.4.4. UAE Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key country dynamic
- 7.7.5.2. Regulatory framework
- 7.7.5.3. Competitive insights
- 7.7.5.4. Kuwait Patient Temperature Management market estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Company Market Position Analysis, 2025
- 8.2. Company Categorization
- 8.3. Company Profiles/Listing
- 8.3.1. 3M Company
- 8.3.1.1. Overview
- 8.3.1.2. Financial performance
- 8.3.1.3. Product benchmarking
- 8.3.1.4. Strategic initiatives
- 8.3.2. Stryker Corporation
- 8.3.2.1. Overview
- 8.3.2.2. Financial performance
- 8.3.2.3. Product benchmarking
- 8.3.2.4. Strategic initiatives
- 8.3.3. Medtronic
- 8.3.3.1. Overview
- 8.3.3.2. Financial performance
- 8.3.3.3. Product benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. Zoll Medical Corporation (Acquired by ASAHI KASEI)
- 8.3.4.1. Overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. BD
- 8.3.5.1. Overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Atom Medical Corp
- 8.3.6.1. Overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Terumo Corporation
- 8.3.7.1. Overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. GE Healthcare
- 8.3.8.1. Overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Nihon Kohden Corporation
- 8.3.9.1. Overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Care Essentials (Cocoon)
- 8.3.10.1. Overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. ICU Medical, Inc.
- 8.3.11.1. Overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Gentherm/Gentherm Incorporated
- 8.3.12.1. Overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
